mmw
☆    

India,
2016-06-23 10:06
(3657 d 18:02 ago)

Posting: # 16448
Views: 2,992
 

 Iron Sucrose [Regulatives / Guidelines]

Post reply
Dear All,

There are many more discussions are available on clinical development for generic version of Iron Sucrose Injection. EMA and FDA has different approaches regarding BE study of Iron Sucrose Injection.

According to the FDA's present draft guidance on Iron Sucrose, bioequivalence should be based on "Maximum value of the difference in concentration between Total Iron and Transferrin-bound Iron over all time points measure."

Could anyone please elaborate FDAs thinking behind this criteria for evaluation?

Thanks in advance

MMW

Edit: Guidance linked; see also this post #3. [Helmut]
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
391 visitors (0 registered, 391 guests [including 26 identified bots]).
Forum time: 04:08 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5